These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 10519389

  • 21. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
    Giehl K, Seidel B, Gierschik P, Adler G, Menke A.
    Oncogene; 2000 Sep 14; 19(39):4531-41. PubMed ID: 11002426
    [Abstract] [Full Text] [Related]

  • 22. Antiinvasive activity of hexadecylphosphocholine in vitro.
    Schallier DC, Bruyneel EA, Storme GA, Hilgard P, Mareel MM.
    Anticancer Res; 1991 Sep 14; 11(3):1285-92. PubMed ID: 1888162
    [Abstract] [Full Text] [Related]

  • 23. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
    Alonso MT, Gajate C, Mollinedo F, Modolell M, Alvarez J, García-Sancho J.
    Br J Pharmacol; 1997 Aug 14; 121(7):1364-8. PubMed ID: 9257915
    [Abstract] [Full Text] [Related]

  • 24. Sensitivity of K562 and HL-60 cells to edelfosine, an ether lipid drug, correlates with production of reactive oxygen species.
    Wagner BA, Buettner GR, Oberley LW, Burns CP.
    Cancer Res; 1998 Jul 01; 58(13):2809-16. PubMed ID: 9661895
    [Abstract] [Full Text] [Related]

  • 25. Cell kill and cytostasis by ET-18-OCH3 and heat.
    Fujiwara K, Modest EJ, Wallen CA.
    Anticancer Res; 1995 Jul 01; 15(4):1333-8. PubMed ID: 7654017
    [Abstract] [Full Text] [Related]

  • 26. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL, Lin MQ, Wang MZ, Yao Z.
    Shi Yan Sheng Wu Xue Bao; 1997 Mar 01; 30(1):73-81. PubMed ID: 10684111
    [Abstract] [Full Text] [Related]

  • 27. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
    Storme GA, Berdel WE, van Blitterswijk WJ, Bruyneel EA, De Bruyne GK, Mareel MM.
    Cancer Res; 1985 Jan 01; 45(1):351-7. PubMed ID: 4038380
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D, Li SL, Hartell JS, Fujita-Yamaguchi Y, Miller JS, Yee D.
    Cancer Res; 2003 Feb 01; 63(3):627-35. PubMed ID: 12566306
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA, Rossi AM, Picotto G, Benassati S, Boland RL.
    J Cell Biochem; 2004 Oct 01; 93(2):384-97. PubMed ID: 15368364
    [Abstract] [Full Text] [Related]

  • 31. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
    Chabot MC, Wykle RL, Modest EJ, Daniel LW.
    Cancer Res; 1989 Aug 15; 49(16):4441-5. PubMed ID: 2743333
    [Abstract] [Full Text] [Related]

  • 32. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
    Dietzfelbinger HF, Kühn D, Zafferani M, Hanauske AR, Rastetter JW, Berdel WE.
    Cancer Res; 1993 Aug 15; 53(16):3747-51. PubMed ID: 8339286
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines.
    Berkovic D, Berkovic K, Fleer EA, Eibl H, Unger C.
    Eur J Cancer; 1994 Aug 15; 30A(4):509-15. PubMed ID: 8018410
    [Abstract] [Full Text] [Related]

  • 34. Differentiation of HL-60 cells distinguishes between cytostatic and cytotoxic effects of the alkylphospholipid ET-18-OCH3.
    Civoli F, Pauig SB, Daniel LW.
    Cancer Chemother Pharmacol; 1996 Aug 15; 38(3):269-72. PubMed ID: 8646802
    [Abstract] [Full Text] [Related]

  • 35. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
    Ahmad I, Filep JJ, Franklin JC, Janoff AS, Masters GR, Pattassery J, Peters A, Schupsky JJ, Zha Y, Mayhew E.
    Cancer Res; 1997 May 15; 57(10):1915-21. PubMed ID: 9157985
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
    Marino-Albernas JR, Bittman R, Peters A, Mayhew E.
    J Med Chem; 1996 Aug 16; 39(17):3241-7. PubMed ID: 8765506
    [Abstract] [Full Text] [Related]

  • 38. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities.
    Unger C, Eibl H, Kim DJ, Fleer EA, Kötting J, Bartsch HH, Nagel GA, Pfizenmaier K.
    J Natl Cancer Inst; 1987 Feb 16; 78(2):219-22. PubMed ID: 3468284
    [Abstract] [Full Text] [Related]

  • 39. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
    Fujiwara K, Koike H, Ohishi Y, Shirafuji H, Kohno I, Modest EJ, Kataoka S.
    Anticancer Res; 1997 Feb 16; 17(3C):2159-67. PubMed ID: 9216681
    [Abstract] [Full Text] [Related]

  • 40. Membrane lipid modification and sensitivity of leukemic cells to the thioether lipid analogue BM 41.440.
    Petersen ES, Kelley EE, Modest EJ, Burns CP.
    Cancer Res; 1992 Nov 15; 52(22):6263-9. PubMed ID: 1423272
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.